Cybin (CYBN) Stock Price, News, Quotes-Moomoo

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Cybin Inc. (CYBN): Among the Best Psychedelic Stocks to Buy in 2025
Yahoo FinanceMar 1 10:56 ET
A. G. P. Maintains Cybin(CYBN.US) With Buy Rating, Maintains Target Price $25
Moomoo NewsFeb 18 08:31 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Cybin (CYBN) and Corbus Pharmaceuticals (CRBP)
TipRanksFeb 18 07:50 ET · Ratings
Wall Street Analysts Think Cybin Inc. (CYBN) Could Surge 988.67%: Read This Before Placing a Bet
Zacks Feb 17 09:00 ET
MGM Resorts To Rally Around 75%? Here Are 10 Top Analyst Forecasts For Thursday
BenzingaFeb 13 08:34 ET
Express News | HC Wainwright & Co. Maintains Buy on Cybin, Lowers Price Target to $150
BenzingaFeb 13 07:52 ET

Comments

Lnova

Feb 17 20:49

Tang Capital 1,330,097 shares, 6.7%
$Cybin (CYBN.US)$
has options
nfa

Cybin | SCHEDULE 13G/A: Others

Teddy123

Feb 11 01:05

Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights

$Cybin (CYBN.US)$
Cybin's Depression Drug Shows Perfect Response Rate, Advances to Pivotal Phase 3 with C$136M War Chest

2

Jaguar8

Feb 10 20:49

NEWS

$Cybin (CYBN.US)$
Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights
Monday, 10th February at 9:48 pm
- Launched strategic clinical site partnerships to accelerate PARADIGM, a multinational pivotal Phase 3 program evaluating CYB003 for the adjunctive treatment of major depressive disorder ("MDD") -
- PARADIGM comprises two 12-week randomized, double-blind, placebo-controlled studies (APPROACH™ and EMBRACE™) and a long-term extension study (EXTEND),...

9